AU2003248868A1 - Coating suspensions (comprising osmopolymers, osmagents) for forming an expandable osmotic composition in controlled release dosage forms as well as the corresponding method for providing this osmotic coating - Google Patents
Coating suspensions (comprising osmopolymers, osmagents) for forming an expandable osmotic composition in controlled release dosage forms as well as the corresponding method for providing this osmotic coating Download PDFInfo
- Publication number
- AU2003248868A1 AU2003248868A1 AU2003248868A AU2003248868A AU2003248868A1 AU 2003248868 A1 AU2003248868 A1 AU 2003248868A1 AU 2003248868 A AU2003248868 A AU 2003248868A AU 2003248868 A AU2003248868 A AU 2003248868A AU 2003248868 A1 AU2003248868 A1 AU 2003248868A1
- Authority
- AU
- Australia
- Prior art keywords
- coating
- coating suspension
- osmotic
- osmopolymer
- film former
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Abandoned
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/10—Dispersions; Emulsions
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0002—Galenical forms characterised by the drug release technique; Application systems commanded by energy
- A61K9/0004—Osmotic delivery systems; Sustained release driven by osmosis, thermal energy or gas
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/075—Ethers or acetals
- A61K31/085—Ethers or acetals having an ether linkage to aromatic ring nuclear carbon
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/28—Dragees; Coated pills or tablets, e.g. with film or compression coating
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Epidemiology (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Dispersion Chemistry (AREA)
- Medicinal Preparation (AREA)
- Paints Or Removers (AREA)
- Separation Using Semi-Permeable Membranes (AREA)
- Paper (AREA)
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US39277502P | 2002-06-28 | 2002-06-28 | |
| US60/392,775 | 2002-06-28 | ||
| PCT/US2003/021361 WO2004002450A1 (en) | 2002-06-28 | 2003-06-28 | Coating suspensions (comprising osmopolymers, osmagents) for forming an expandable osmotic composition in controlled release dosage forms as well as the corresponding method for providing this osmotic coating |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| AU2003248868A1 true AU2003248868A1 (en) | 2004-01-19 |
Family
ID=30000934
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| AU2003248868A Abandoned AU2003248868A1 (en) | 2002-06-28 | 2003-06-28 | Coating suspensions (comprising osmopolymers, osmagents) for forming an expandable osmotic composition in controlled release dosage forms as well as the corresponding method for providing this osmotic coating |
Country Status (15)
| Country | Link |
|---|---|
| US (1) | US7338663B2 (cg-RX-API-DMAC7.html) |
| EP (1) | EP1528913A1 (cg-RX-API-DMAC7.html) |
| JP (1) | JP2005532374A (cg-RX-API-DMAC7.html) |
| KR (1) | KR20050071375A (cg-RX-API-DMAC7.html) |
| CN (1) | CN1678292A (cg-RX-API-DMAC7.html) |
| AR (1) | AR040301A1 (cg-RX-API-DMAC7.html) |
| AU (1) | AU2003248868A1 (cg-RX-API-DMAC7.html) |
| CA (1) | CA2490683A1 (cg-RX-API-DMAC7.html) |
| IL (1) | IL165864A0 (cg-RX-API-DMAC7.html) |
| MX (1) | MXPA05000207A (cg-RX-API-DMAC7.html) |
| NO (1) | NO20050181L (cg-RX-API-DMAC7.html) |
| NZ (1) | NZ537343A (cg-RX-API-DMAC7.html) |
| TW (1) | TW200414900A (cg-RX-API-DMAC7.html) |
| WO (1) | WO2004002450A1 (cg-RX-API-DMAC7.html) |
| ZA (1) | ZA200500826B (cg-RX-API-DMAC7.html) |
Families Citing this family (10)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US6440457B1 (en) * | 1993-05-27 | 2002-08-27 | Alza Corporation | Method of administering antidepressant dosage form |
| US7241805B2 (en) | 2005-06-27 | 2007-07-10 | Biovail Laboratories, Inc. | Modified release formulations of a bupropion salt |
| CA2655596C (en) * | 2006-06-27 | 2011-10-25 | Biovail Laboratories International Srl | Multiparticulate osmotic delivery system |
| US7538652B2 (en) * | 2006-08-29 | 2009-05-26 | International Business Machines Corporation | Electrical component tuned by conductive layer deletion |
| US20090004281A1 (en) * | 2007-06-26 | 2009-01-01 | Biovail Laboratories International S.R.L. | Multiparticulate osmotic delivery system |
| US7824557B2 (en) * | 2007-08-08 | 2010-11-02 | General Electric Company | Method for controlling microbial biofilm in aqueous systems |
| US7785478B2 (en) * | 2007-08-08 | 2010-08-31 | General Electric Company | Method for controlling protozoa that harbor bacteria |
| US8784659B2 (en) * | 2007-08-08 | 2014-07-22 | General Electric Company | Method for controlling microbial biofilm in aqueous systems |
| US20110052655A1 (en) * | 2007-08-08 | 2011-03-03 | Wilson Kurt Whitekettle | Methods and vesicles for controlling protozoa |
| CN102871982B (zh) | 2012-10-16 | 2014-09-10 | 中国科学院上海药物研究所 | 一种药物渗透泵制剂 |
Family Cites Families (7)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US36472A (en) * | 1862-09-16 | Cttlvebt | ||
| US4765989A (en) * | 1983-05-11 | 1988-08-23 | Alza Corporation | Osmotic device for administering certain drugs |
| US5324280A (en) * | 1990-04-02 | 1994-06-28 | Alza Corporation | Osmotic dosage system for delivering a formulation comprising liquid carrier and drug |
| US5443459A (en) * | 1991-01-30 | 1995-08-22 | Alza Corporation | Osmotic device for delayed delivery of agent |
| US5800422A (en) * | 1995-06-02 | 1998-09-01 | Alza Corporation | Osmotic device with delayed activation of drug delivery and complete drug release |
| DE69915346T2 (de) * | 1998-12-17 | 2004-07-22 | Alza Corp., Mountain View | Umwandlung von flüssigkeitsgefüllten gelatinkapseln in systeme mit gesteuerter wirkstoffabgabe durch mehrfache beschichtungen |
| US6352721B1 (en) * | 2000-01-14 | 2002-03-05 | Osmotica Corp. | Combined diffusion/osmotic pumping drug delivery system |
-
2003
- 2003-06-27 AR ARP030102341A patent/AR040301A1/es not_active Application Discontinuation
- 2003-06-27 TW TW92117738A patent/TW200414900A/zh unknown
- 2003-06-28 US US10/609,061 patent/US7338663B2/en not_active Expired - Lifetime
- 2003-06-28 CA CA002490683A patent/CA2490683A1/en not_active Abandoned
- 2003-06-28 NZ NZ537343A patent/NZ537343A/en not_active IP Right Cessation
- 2003-06-28 KR KR1020047021455A patent/KR20050071375A/ko not_active Withdrawn
- 2003-06-28 MX MXPA05000207A patent/MXPA05000207A/es not_active Application Discontinuation
- 2003-06-28 CN CNA038206978A patent/CN1678292A/zh active Pending
- 2003-06-28 WO PCT/US2003/021361 patent/WO2004002450A1/en not_active Ceased
- 2003-06-28 JP JP2004518242A patent/JP2005532374A/ja not_active Withdrawn
- 2003-06-28 EP EP03762340A patent/EP1528913A1/en not_active Withdrawn
- 2003-06-28 AU AU2003248868A patent/AU2003248868A1/en not_active Abandoned
- 2003-06-28 IL IL16586403A patent/IL165864A0/xx unknown
-
2005
- 2005-01-12 NO NO20050181A patent/NO20050181L/no not_active Application Discontinuation
- 2005-01-27 ZA ZA200500826A patent/ZA200500826B/xx unknown
Also Published As
| Publication number | Publication date |
|---|---|
| TW200414900A (cg-RX-API-DMAC7.html) | 2004-08-16 |
| EP1528913A1 (en) | 2005-05-11 |
| MXPA05000207A (es) | 2005-06-06 |
| US7338663B2 (en) | 2008-03-04 |
| NZ537343A (en) | 2007-06-29 |
| CN1678292A (zh) | 2005-10-05 |
| JP2005532374A (ja) | 2005-10-27 |
| KR20050071375A (ko) | 2005-07-07 |
| WO2004002450A1 (en) | 2004-01-08 |
| NO20050181L (no) | 2005-01-12 |
| CA2490683A1 (en) | 2004-01-08 |
| US20040058002A1 (en) | 2004-03-25 |
| ZA200500826B (en) | 2006-08-30 |
| AR040301A1 (es) | 2005-03-23 |
| IL165864A0 (en) | 2006-01-15 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP4703470B2 (ja) | エチルセルローズ水性分散液で被覆した放出制御製剤 | |
| US9211267B2 (en) | Preparation in film form for biphasic release of pharmacologically active or other substances | |
| FI110160B (fi) | Molekyylipainoltaan erilaisia polymeerejä ja lääkeainetta sisältävän annosmuodon valmistusmenetelmä | |
| JP2010270133A (ja) | 個々に投薬でき、液体に接触すると急速に分解する活性物質含有および特に芳香物含有膜状投与形態 | |
| JPH08511257A (ja) | アステミゾールとプソイドエフェドリンの長期放出型フィルムコーティング錠剤 | |
| EP1499289A2 (en) | Volume efficient controlled release dosage form | |
| US7338663B2 (en) | Expandable osmotic composition and coating suspension | |
| HU206265B (en) | Process for producing pharmaceutical compositions comprising morphine | |
| Yuen et al. | Development and in-vitro evaluation of a multiparticulate sustained release theophylline formulation | |
| FR2555897A1 (fr) | Systeme d'apport, a debit constant et a liberation pulsee, de substances a un milieu environnant | |
| JP2567427B2 (ja) | 浸透分配経口投与製剤 | |
| JP5146859B2 (ja) | アクリル系ポリマーの水性分散液で被膜した放出制御型製剤及びその方法 | |
| JPH08175977A (ja) | アクリル系ポリマーの水性分散液で被覆した放出制御型製剤及びその製法 | |
| Gami et al. | DESIGN AND EVALUATION STUDY OF PULSATILE RELEASE TABLETS OF METOPROLOL SUCCINATE. | |
| ES2430333T3 (es) | Composiciones de matriz para liberación controlada de principios activos | |
| CA2807225A1 (en) | Pharmaceutical preparation for controlling water-soluble drug release | |
| JP2008024708A (ja) | アクリル系ポリマーの水性分散液で被膜した放出制御型製剤及びその方法 | |
| CZ25293A3 (cs) | Bioaktivní přípravek | |
| HK1182027A (en) | Pharmaceutical preparation for controlling water-soluble drug release |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| MK5 | Application lapsed section 142(2)(e) - patent request and compl. specification not accepted |